Epic's February 2026 AI Charting rollout is a distribution play. When ambient AI is native to the EHR — launched with one button inside the same system the clinician already uses for everything else — the room for standalone tools compresses. You do not need to download an app, switch contexts, or manage a separate subscription. The AI is just there, inside Epic, as a feature.
OpenEvidence Visits is an intelligence play. It is a documentation, communication, and coding suite that embeds OpenEvidence's clinical decision AI into every step — with evidence-grounded recommendations appearing alongside the notes, during patient calls, and within the coding workflow. The Sutter Health partnership brings it inside Epic via FHIR integration, but it is still a separate layer with its own intelligence architecture.
The question that matters is not which product has better features. It is which distribution model wins — and under what conditions.
When the EHR Wins
Epic's native AI wins when the clinician's primary need is documentation efficiency within the EHR they already use. If the goal is "write my notes faster inside Epic," a native feature that requires zero implementation, zero context switching, and zero additional cost (beyond the Epic licence) has an overwhelming distribution advantage.
Large health systems already invested in Epic will default to native features because IT governance, procurement, and support are simpler. The ambient AI is certified by Epic, maintained by Epic, and updated by Epic. There is no additional vendor to manage.
When the Evidence Engine Wins
OpenEvidence Visits wins when the clinician needs more than documentation — specifically, evidence-grounded clinical decision support during the encounter, integrated patient communications (calls, messages, faxes) with AI documentation, and coding intelligence that connects the note to reimbursement.
Epic's native AI Charting does not generate evidence-based clinical recommendations from peer-reviewed literature. OpenEvidence does. This is the intelligence gap. A clinician who wants the AI to not only document the conversation but also surface relevant clinical evidence, suggest guideline-aligned management, and generate billing codes with MDM rationale needs the evidence engine, not just the charting engine.
OpenEvidence also wins for individual clinicians and smaller practices who do not use Epic — where the EHR-native advantage disappears entirely. OpenEvidence's free access for verified US HCPs makes it available to any clinician regardless of institutional affiliation.
The UK Perspective
In UK general practice, Epic is not the dominant clinical system — EMIS and SystmOne are. The Epic-native distribution advantage does not apply to the vast majority of UK clinicians.
For UK practices, the distribution question is different: when will EMIS or SystmOne offer native ambient AI, and until then, which standalone tools provide the best combination of documentation and clinical reference?
The documentation answer in the UK today is Heidi, TORTUS, or Accurx Scribe. The clinical reference answer is iatroX — free, UK guideline-grounded, and designed for the 10-minute NHS consultation rather than the US clinical workflow.
The strategic lesson from the Epic vs OpenEvidence dynamic applies universally: the tool that is embedded in your existing workflow has a distribution advantage, but the tool that provides intelligence beyond documentation has a capability advantage. The clinician's choice depends on which advantage matters more for their specific practice.
Conclusion
Epic AI Charting and OpenEvidence Visits are competing for the same workflow slot with fundamentally different strategies: distribution (native EHR embedding) versus intelligence (evidence-grounded AI across documentation, communication, and coding). Both will succeed — in different segments, for different reasons.
For UK clinicians, the immediate lesson is that the knowledge layer — guideline-grounded clinical reference — remains essential regardless of which documentation or workflow tool you use. The AI that writes your notes is becoming smarter. The AI that verifies your clinical reasoning needs to be smarter still.